Sheng-Huei Wang1, Wu-Chien Chien2,3, Chi-Hsiang Chung2, Fu-Huang Lin2, Chung-Kan Peng1,4, Chih-Feng Chian1, Chih-Hao Shen1. 1. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. 2. School of Public Health, National Defense Medical Center, Taipei, Taiwan. 3. Department of Medical Research, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. 4. Institute of Undersea and Hyperbaric Medicine, National Defense Medical Center, Taipei, Taiwan.
Abstract
BACKGROUND AND OBJECTIVE: According to several studies, tuberculosis (TB) may be involved in the pathogenesis of cardiovascular disease. However, the relationship between TB and peripheral arterial disease (PAD) has not been studied. The aim of this study was to investigate whether patients with TB exhibit an increased risk of developing PAD. METHODS: The data assessed in this national population-based cohort study were obtained from the Taiwan National Health Insurance Database from 2000 to 2010. Patients with newly diagnosed TB were selected using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. The non-TB cohort was randomly frequency-matched to the TB cohort at a ratio of 2:1 according to age, sex and index year. Cox's proportional hazards regression models were used to analyse the risk of PAD. RESULTS: We enrolled 14 350 patients with TB and 28 700 controls in this study. The risk of PAD was 3.93-fold higher in the patients with TB than in the non-TB controls after adjusting for age, sex, co-morbidities and socio-economic status. Based on the subgroup analysis, the TB cohort exhibited an increased risk of developing PAD compared with the non-TB cohort, regardless of age, sex, co-morbidities and socio-economic status. Patients with TB had a higher risk of developing PAD than healthy control subjects after 1 year of follow-up. CONCLUSION: Patients with TB have a significantly higher risk of developing PAD than patients without TB. TB should be considered when evaluating a patient's risk of developing PAD.
BACKGROUND AND OBJECTIVE: According to several studies, tuberculosis (TB) may be involved in the pathogenesis of cardiovascular disease. However, the relationship between TB and peripheral arterial disease (PAD) has not been studied. The aim of this study was to investigate whether patients with TB exhibit an increased risk of developing PAD. METHODS: The data assessed in this national population-based cohort study were obtained from the Taiwan National Health Insurance Database from 2000 to 2010. Patients with newly diagnosed TB were selected using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. The non-TB cohort was randomly frequency-matched to the TB cohort at a ratio of 2:1 according to age, sex and index year. Cox's proportional hazards regression models were used to analyse the risk of PAD. RESULTS: We enrolled 14 350 patients with TB and 28 700 controls in this study. The risk of PAD was 3.93-fold higher in the patients with TB than in the non-TB controls after adjusting for age, sex, co-morbidities and socio-economic status. Based on the subgroup analysis, the TB cohort exhibited an increased risk of developing PAD compared with the non-TB cohort, regardless of age, sex, co-morbidities and socio-economic status. Patients with TB had a higher risk of developing PAD than healthy control subjects after 1 year of follow-up. CONCLUSION:Patients with TB have a significantly higher risk of developing PAD than patients without TB. TB should be considered when evaluating a patient's risk of developing PAD.
Authors: Moises A Huaman; Eduardo Ticona; Gustavo Miranda; Richard J Kryscio; Raquel Mugruza; Ernesto Aranda; Paola L Rondan; David Henson; Cesar Ticona; Timothy R Sterling; Carl J Fichtenbaum; Beth A Garvy Journal: Clin Infect Dis Date: 2018-03-05 Impact factor: 9.079
Authors: Paul A Agius; Julia C Cutts; Peige Song; Igor Rudan; Diana Rudan; Victor Aboyans; Mary M McDermott; Michael H Criqui; F Gerald R Fowkes; Freya J I Fowkes Journal: J Epidemiol Glob Health Date: 2022-07-16
Authors: Moises A Huaman; Joseph E Qualls; Shinsmon Jose; Stephanie M Schmidt; Anissa Moussa; David G Kuhel; Eddy Konaniah; Ravi K Komaravolu; Carl J Fichtenbaum; George S Deepe; David Y Hui Journal: Front Immunol Date: 2020-12-18 Impact factor: 7.561
Authors: Moises A Huaman; Carlo N De Cecco; Marcio S Bittencourt; Eduardo Ticona; Cissy Kityo; Isabel Ballena; Sophie Nalukwago; Rashidah Nazzinda; Cesar Ticona; Ruben Azañero; Bin Zhang; Carey Farquhar; Thomas R Hawn; Timothy R Sterling; Carl J Fichtenbaum; Chris T Longenecker Journal: Clin Infect Dis Date: 2021-11-02 Impact factor: 9.079